Details of the Drug Formulaction

General Information of Drug Formulation (ID: F02047)

• Formulation Name: Atorvastatin 40 mg tablet
• Company: Aphena Pharma Solutions-Tennessee; Avera McKennan Hospital; Mylan Pharamceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Atorvastatin	(DMF28YC)	Acute coronary syndrome	BA41	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Arginine	(E00112)	6322	Buffering agent; Dispersing agent
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Carbonic acid disodium salt	(E00199)	10340	Alkalizing agent; Buffering agent; Diluent; Dispersing agent
Carmellose sodium	(E00625)	Not Available	Disintegrant
Magnesium stearate	(E00208)	11177	lubricant
Polyvinyl alcohol	(E00666)	Not Available	Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Soybean lecithin	(E00637)	Not Available	Other agent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent